| IDF definition | NCEP ATP III | the AHA/NHLBI |
---|---|---|---|
 | Central obesity plus any two of the following four additional factors | Three or more of the following five factors | Three or more of the following five factors |
1 | Central obesity: waist circumference ≥ 90 cm in men and ≥ 80 cm in women | central obesity: waistcircumference ≥ 102 cm in men and ≥ 88 cm in women | Same as NCEP APT III |
2 | Hypertriglyceridemia triglyceride level ≥ 1.7mmol/L; | Same as IDF | Same as NCEP APT III |
3 | High blood pressure ≥ 130/85mm Hgor treatment of previously diagnosed hypertension; | Same as IDF | Same as NCEP APT III |
4 | Reduced high-density lipoprotein (HDL)-cholesterol < 1.03mmol/L in men and < 1.29mmol/L in women, or specific treatment for these lipid abnormalities; | Same as IDF | Same as NCEP APT III |
5 | Hyperglycemia: fasting glucose level of ≥ 5.6mmol/L or treatment of previously diagnosed type 2 diabetes | Hyperglycemia: fasting glucose level of ≥ 6.1mmol/L or treatment of previously diagnosed type 2 diabetes | Hyperglycemia:fasting glucose level of ≥ 5.6mmol/L or previously diagnosed type 2 diabetes. |